Gluskin Sheff & Assoc Inc Zoetis Inc. Transaction History
Gluskin Sheff & Assoc Inc
- $788 Million
- Q2 2025
A detailed history of Gluskin Sheff & Assoc Inc transactions in Zoetis Inc. stock. As of the latest transaction made, Gluskin Sheff & Assoc Inc holds 4,941 shares of ZTS stock, worth $721,830. This represents 0.1% of its overall portfolio holdings.
Number of Shares
4,941
Previous 7,084
30.25%
Holding current value
$721,830
Previous $1.17 Million
33.96%
% of portfolio
0.1%
Previous 0.16%
Shares
23 transactions
Others Institutions Holding ZTS
# of Institutions
2,120Shares Held
430MCall Options Held
1.47MPut Options Held
1.45M-
Vanguard Group Inc Valley Forge, PA41.9MShares$6.12 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY36.8MShares$5.38 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.7MShares$2.88 Billion0.12% of portfolio
-
Morgan Stanley New York, NY17.7MShares$2.59 Billion0.19% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL15.9MShares$2.32 Billion2.21% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $68.4B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...